|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6886 | |
| A61K 31/517 | |||
| A61K 31/58 |
| (11) | Patento numeris | 2694959 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12765178.4 |
| Europos patento paraiškos padavimo data | 2012-03-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-02-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/031662 |
| Data | 2012-03-30 |
| (87) | Numeris | WO 2012/135749 |
| Data | 2012-10-04 |
| (30) | Numeris | Data | Šalis |
| 201161471036 P | 2011-04-01 | US |
| (72) |
LIN, Kui, US
PUNNOOSE, Elizabeth, US
SESHAGIRI, Somasekar, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
|
| (54) | BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS |
| BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS |